On the other hand, JMJD5 is downregulated in hepatocellular carcinoma [31] and pancreatic cancer [32] and negatively regulates cancer progression, indicating heterogeneity of JMJD5 among different tumor types. This evidence concerns the gene KDM8 and hepatocellular carcinoma.